Presentation is loading. Please wait.

Presentation is loading. Please wait.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Published byἩρωδιάς Λόντος Modified over 5 years ago

Similar presentations

Presentation on theme: "Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology."— Presentation transcript:

1 Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 39, Issue 45, 26 August 2018, Pages 3999–4008, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 1 Trial flowchart.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 39, Issue 45, 26 August 2018, Pages 3999–4008, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Take home figure The Kaplan–Meier curves comparing cumulative incidence of the primary and secondary endpoints in the two ... Take home figure The Kaplan–Meier curves comparing cumulative incidence of the primary and secondary endpoints in the two study groups. (A) The cumulative incidence of the primary composite outcome of death due to heart failure, or hospitalization due to heart failure, or worsening heart failure is shown. (B) The cumulative incidence of patients who died from heart failure or were hospitalized for heart failure is shown. (C) The cumulative incidence of patients who died from any cause is shown. The event rates at one at 2 years of follow-up are shown (D) The cumulative incidence of patients who were hospitalized for heart failure is shown.. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 39, Issue 45, 26 August 2018, Pages 3999–4008, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 2 Subgroup analyses of the primary endpoint
Figure 2 Subgroup analyses of the primary endpoint. Hazard ratio and P values for interaction are based on Cox ... Figure 2 Subgroup analyses of the primary endpoint. Hazard ratio and P values for interaction are based on Cox logistic-regression analyses. There was a significant interaction of the primary endpoint (death from heart failure, or hospitalization for heart failure, or worsening heart failure) with ejection fraction and Specific Symptom Scale, which implies that patients with an ejection fraction ≤35% and those with more symptomatic atrial fibrillation (Specific Symptom Scale >31) are more likely to benefit from AV junction ablation and cardiac resynchronization therapy pacing. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 39, Issue 45, 26 August 2018, Pages 3999–4008, The content of this slide may be subject to copyright: please see the slide notes for details.

5 Figure 3 Symptoms and physical limitations assessed by Specific Symptom Scale score, at the baseline and at 1 year ... Figure 3 Symptoms and physical limitations assessed by Specific Symptom Scale score, at the baseline and at 1 year follow-up visit. On-treatment analysis in patients with ejection fraction ≤35% and in those with ejection fraction >35%. Mean values and 95% confidence interval are reported. EF, ejection fraction; SSS, specific symptom scale. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 39, Issue 45, 26 August 2018, Pages 3999–4008, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology."

Similar presentations

Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.

Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.

Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.
Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.

Figure 1 Periprocedural myonecrosis and myocardial infarction after left main coronary artery revascularization with ... Figure 1 Periprocedural myonecrosis.
Figure 1 Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data ... Figure 1 Subject phenotypes.

Figure 1 Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data ... Figure 1 Subject phenotypes.
Figure 1 Study flow diagram and definition of clinical response

Figure 1 Study flow diagram and definition of clinical response
Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.

Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Multivariable-adjusted predictors of PAC

Figure 1 Multivariable-adjusted predictors of PAC
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.

(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Similar presentations

Ads by Google